Philadelphia biotech firm backed by more than $130M names new CEO
A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.
Northern Ontario mom trying to raise awareness, hope for families dealing with rare diseases
Her mother, Kelsey, living in Espanola, about 40 minutes west of Sudbury, welcomes all the activity because Iris has a rare, ...
pharmaphorum6d
Sanofi extends its Pompe range with first Nexviazyme OK
Sanofi has added another string to its Pompe disease therapy bow, after getting FDA approval for Nexviazyme, its latest therapy for the rare, inherited disorder. The US regulator has approved ...
technologynetworks4d
How Cells Recycle Important Fat Molecules To Stay Healthy
New research has made a breakthrough in understanding how our cells manage to stay healthy by recycling important fat ...